NovaBridge Biosciences
NBP·Stocks·Pharmaceuticals Major·United States·Nasdaq·USD
Price
$1.44
Today
-5.9%
YTD
-61.7%
About
Operating within the People's Republic of China and the US, I-Mab is a clinical-stage biopharmaceutical company that discovers and develops treatments for diseases such as cancer and autoimmune disorders. Founded in 2014, the company is based in Shanghai, the People's Republic of China. I-Mab is listed under the IMAB ticker on NASDAQ GS. Learn more about IMAB stock by adding it to your eToro watchlist.
Price chart
Closing price history for NBP (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-4.30
P/S (TTM)0.00
P/B (TTM)0.95
Market cap$219.23M
Cap tierMicro-cap
Industry avg P/E-43.36
Profitability
Gross margin39.64%
EBIT margin0.00%
Net margin-8673.15%
ROE-22.44%
ROA-17.12%
Earnings & Revenue
Revenue (TTM)$0.00
Revenue growth (1Y)-100.0%
EPS (TTM)-$0.44
Free cash flowUnknown
Total debt$3.07M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.07
Employees30
Next earnings8 Mar '27
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.